View this email in your browser
This conference newsletter will keep you updated on new and relevant developments regarding LxAddictions 2019 (23-25 October 2019).

Spotlight on co-production

For the 2019 edition of Lisbon Addictions we have adopted a new approach to shaping the conference programme. We will work closely with co-producers in order to develop a rich, diverse and innovative programme by taking joint responsibility for organising thematic tracks around selected topics. The co-producers will build coherent packages of topical strands, sessions and guided poster tours.
LxAddictions19 co-producers
European Federation of Addiction Societies (EUFAS)
EUFAS will develop a track on ‘Progress in alcohol research and treatment’, focussing on alcohol use and related disorders, covering a broad range from alcohol-use trends, epidemiology of alcohol use disorders to underlying neuroscientific findings and treatment innovations.

Addictions in the future’ will focus on prospective policy action to address specific key issues (identified through an on-going participatory process) related to four broad areas in addiction: future challenges in prevention; reducing harm from addiction across the spectrum; therapeutic horizons; and innovation in monitoring — challenges in generating evidence.

International Network on Hepatitis in Substance Users (INHSU)
INHSU will bring together stakeholders in the areas of drug user health and HCV to discuss ‘The future of hepatitis C among people who inject drugs: new frontiers for policy, practice and science’.

International Society for the Study of Drug Policy (ISSDP)
‘Improving the data, methods and analysis used to inform drug policy’ is the track organised by ISSDP. It will showcase the variety of drug policy approaches being adopted globally to provide evidence for improved policymaking going forward.

Journal on Behavioural Addictions
The track co-produced by the Journal on Behavioural Addictions will introduce non-substance-related disorders (including gambling, problematic video game use, internet addiction, problematic social media use, exercise addiction, compulsive buying behaviour), discuss their phenomenology, etiology, assessment, epidemiology and other relevant characteristics as well as the main problematic issues emerging in connection with these phenomena.

Society for the Study of Addiction (SSA)
This thematic track will focus on opioid-related deaths, mainly in Europe and Australia and will be organised by the SSA. It will include discussion of data from countries where opioid-related deaths have been increasing, as well as emerging trends in terms of age and gender distribution, the contribution of polydrug use, and the proportion of deaths attributable to pharmaceutical opioid drugs.
Update on keynote speakers
Henrietta Bowden-Jones, OBE is a medical doctor and neuroscience researcher working as Consultant psychiatrist in Addictions. Dr Bowden-Jones is the Founder and Director of the National Problem Gambling Clinic (London). The clinic was the first National Health Service multidisciplinary treatment centre in the UK for the treatment of problem gamblers. It has received more than 4000 referrals since its opening in 2008 and holds the only extensive national database on pathological gambling. Dr Bowden-Jones is the current President of the Medical Women's Federation.
Karl Erik Lund is Senior Researcher at the Norwegian Institute of Public Health. He has been involved in tobacco control work since the mid-1980s. Dr Lund received the Norwegian Medical Association’s Award in preventive medicine in 2000. He has published extensively on tobacco research, lectured on tobacco topics in several countries worldwide, and been called to give talks before authorities in many countries. His recent contribution to the research community revolves around the new generations of electronic delivery systems for nicotine uptake, such as the ‘heat-not-burn’ products.
Sharon L. Walsh is Director of the Center on Drug and Alcohol Research (USA). She is Professor of Behavioral Science, Pharmacology, Pharmaceutical Sciences and Psychiatry at the University of Kentucky. She is appointed Special Government Employee of the Food and Drug Administration and serves in an advisory capacity for new drug approvals of analgesic formulations and risk management approaches for marketed drugs with abuse liability.
See all confirmed keynote speakers >>

FuturiZe bursaries: Deadline extension to 15 April

Due to increased interest in the FuturiZe participatory process and bursaries, FuturiZe has decided to extend the deadline for bursary applications (and the separate consultation survey) until 18h CET+1 on Monday 15 April.

The FuturiZe debates at #LxAddictions19 will focus on policy action to address specific key issues on four wide-ranging addiction topics.

Register for LxAddictions19 >>
Copyright © 2019 EMCDDA, All rights reserved.